The Rotation of Disinfectants Principle: True or False? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Rotation of Disinfectants Principle: True or False?
The author defines sanitizers, disinfectants, and antibiotics, and examines the question of whether the rotation of disinfectants is scientifically warranted.


Pharmaceutical Technology
Volume 33, Issue 2, pp. 58-71

75. P.G. Ambrose et al., "New Generations of Quinolones: with Particular Attention to Levofloxacin," Conn. Med. 61, 269–272 (1997).

76. L. Ferrero, B. Cameron, and J. Crouzet, "Analysis of gyrA and grlA Mutations in Stepwise-Selected Ciprofloxacin-Resistant Mutants of Staphylococcus aureus, " AAC. 39, 1554–1558 (1995).

77. P. Heisig, "Genetic Evidence for a Role of parC Mutations in Development of High Level Fluoroquinolone Resistance in Escherichia coli, " AAC. 40, 879–885 (1996).

78. C. Janoir et al., "High-Level Fluoroquinolone Resistance in Streptococcus pneumoniae Requires Mutations in parC and gyrA," AAC. 40, 2760–2764 (1996).

79. X.S. Pan and L.M. Fisher, "DNA Gyrase and Topoisomerase IV Are Dual Targets of Clinafloxacin Action in Streptococcus pneumoniae, " AAC. 42, 2810–2816 (1998).

80. H. Taba and N. Kusano, "Sparfloxacin Resistance in Clinical Isolates of Streptococcus pneumoniae : Involvement of Multiple Mutations in gyrA and parC Genes", AAC. 42, 2193–2196 (1998).

81. X. Zhao et al., "DNA Topoisomerse Targets of the Fluoroquinolones: A Strategy for Avoiding Bacterial Resistance," Proc. Natl. Acad. Sci. U.S.A. 94, 13991–13996 (1997).

82. D.C. Hooper, "Mode of Action of Fluoroquinolones," Drugs 58 (suppl 2), 6–10 (1999).

83. C. Siporin, "The Evolution of Fluorinated Quinolones: Pharmacology, Microbiological Activity, Clinical Uses, and Toxicities," Annu. Rev. Microbiol. 43, 601–627 (1989).

84. H. Hiasa, D.O. Yousef, and K.J. Marains, "DNA Strand Cleavage Is Required for Replication Fork Arrest by a Frozen Topoisomerase-Quinolone-DNA Ternary Complex," J. Biol. Chem. 271, 26424–26429 (1996).

85. C.R. Chen et al., "DNA Gyrase and Topoisomerase IV on the Bacterial Chromosome: Quinolone-Induced DNA Cleavage," J. Mol. Biol. 258, 627–637 (1996).

86. R.A. Nicholas, H. Hamilton, and M.S. Cohen, "Beta-Lactam Antibiotics," in Principles of Pharmacology, P.L. Munson, R.A. Mueller, and G.R. Breese, Eds. (Chapman and Hall, NY, 1995), p. 95.

87. K. Poole, "Resistance to Beta-Lactam Antibiotics," Cell. Mol. Life Sci. 61 (17), 2200–2223 (2004).

88. "Antibiotics—Protein Synthesis, Nucleic Acid Synthesis, and Metabolism," in Microbiology and Immunology, University of South Carolina, http://pathmicro.med.sc.edu/fox/antibiotics1.htm accessed Jan. 18, 2009.

89. G.M. Brown, "The Biosynthesis of Folic Acid II: Inhibition by Sulfonamides," J. Biol. Chem. 237, 536–540 (1962).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here